Dartmouth researchers conducted the first clinical trial of a therapy chatbot powered by generative AI and found that the software resulted in significant improvements in participants’ symptoms, according to results published in NEJM AI, a journal from the publishers of the New England Journal of Medicine.
People in the study also reported they could trust and communicate with the system, known as Therabot, to a degree that is comparable to working with a mental-health professional.